Cargando…

Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now?

SIMPLE SUMMARY: Research has clearly shown a connection between the respiratory tract microbiome and lung cancer. The composition and metabolism of the bacterial community in lung cancer patients differ from those in healthy individuals. Further large-scale studies are needed to understand the micro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czarnecka-Chrebelska, Karolina H., Kordiak, Jacek, Brzeziańska-Lasota, Ewa, Pastuszak-Lewandoska, Dorota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605430/ https://www.ncbi.nlm.nih.gov/pubmed/37894302 http://dx.doi.org/10.3390/cancers15204935

Ejemplares similares

A Strong Decrease in TIMP3 Expression Mediated by the Presence of miR-17 and 20a Enables Extracellular Matrix Remodeling in the NSCLC Lesion Surroundings
por: Czarnecka, Karolina H., et al.
Publicado: (2019)

Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients
por: Pastuszak-Lewandoska, Dorota, et al.
Publicado: (2015)

The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma
por: Pastuszak-Lewandoska, Dorota, et al.
Publicado: (2018)

Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis
por: Antczak, Adam, et al.
Publicado: (2013)

CTLA-4 Expression and Polymorphisms in Lung Tissue of Patients with Diagnosed Non-Small-Cell Lung Cancer
por: Antczak, Adam, et al.
Publicado: (2013)

Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
por: Kryczka, Jolanta, et al.
Publicado: (2021)

Expression of inflammatory interleukins and selected miRNAs in non-small cell lung cancer
por: Dutkowska, Agata, et al.
Publicado: (2021)

Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer
por: Migdalska-Sęk, Monika, et al.
Publicado: (2021)

Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
por: Czarnecka, Karolina H., et al.
Publicado: (2013)

Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
por: Pastuszak-Lewandoska, Dorota, et al.
Publicado: (2014)

Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell
por: Migdalska-Sęk, Monika, et al.
Publicado: (2019)

Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
por: Kryczka, Jolanta, et al.
Publicado: (2021)

Role of Beta-Carotene in Lung Cancer Primary Chemoprevention: A Systematic Review with Meta-Analysis and Meta-Regression
por: Kordiak, Jacek, et al.
Publicado: (2022)

The ovarian cancer oncobiome
por: Banerjee, Sagarika, et al.
Publicado: (2017)

Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance—promising for molecular staging of prostate cancers
por: Bryś, Magdalena, et al.
Publicado: (2013)

Panel of miR-150 and linc00673, regulators of CCR6/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer
por: Baran, Kamila, et al.
Publicado: (2023)

Altered miRNA expression in pulmonary sarcoidosis
por: Kiszałkiewicz, Justyna, et al.
Publicado: (2016)

The Oncobiome in Gastroenteric and Genitourinary Cancers
por: D’Antonio, Domenica Lucia, et al.
Publicado: (2022)

Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients
por: Piotrowski, Wojciech J., et al.
Publicado: (2015)

Expression analysis of selected classes of circulating exosomal miRNAs in soccer players as an indicator of adaptation to physical activity
por: Domańska-Senderowska, Daria, et al.
Publicado: (2017)

The Significance of the Alter miR let-7a and miR-335 Expression Level Regulating the CCR7/CCL19 Axis as Potential Biomarkers of Tumor Progression in NSCLC
por: Baran, Kamila, et al.
Publicado: (2022)

Helicobacter Pylori and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer – a Pilot Study
por: Dzikowiec, Magdalena, et al.
Publicado: (2022)

CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves’ disease and Hashimoto's thyroiditis)
por: Pastuszak-Lewandoska, Dorota, et al.
Publicado: (2012)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Evaluation of selected IL6/STAT3 pathway molecules and miRNA expression in chronic obstructive pulmonary disease
por: Kiszałkiewicz, J. M., et al.
Publicado: (2021)

The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients
por: Baran, Kamila, et al.
Publicado: (2023)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Relationships between the Expression of the ACTN3 Gene and Explosive Power of Soccer Players
por: Domańska-Senderowska, Daria, et al.
Publicado: (2019)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Breast cancer: the first comparative evaluation of oncobiome composition between males and females
por: Niccolai, Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_87eo918jvdk8i9mp8ipv17epu2